Revolution Medicines Research and Development Expenses 2018-2024 | RVMD

Revolution Medicines research and development expenses for the twelve months ending September 30, 2024 were $0.553B, a 62.32% increase year-over-year.

  • Revolution Medicines annual research and development expenses for 2023 were $0.423B, a 67.2% increase from 2022.
  • Revolution Medicines annual research and development expenses for 2022 were $0.253B, a 35.37% increase from 2021.
  • Revolution Medicines annual research and development expenses for 2021 were $0.187B, a 41.36% increase from 2020.

Revolution Medicines Research and Development Expenses 2018-2024 | RVMD

  • Revolution Medicines annual research and development expenses for 2023 were $0.423B, a 67.2% increase from 2022.
  • Revolution Medicines annual research and development expenses for 2022 were $0.253B, a 35.37% increase from 2021.
  • Revolution Medicines annual research and development expenses for 2021 were $0.187B, a 41.36% increase from 2020.